C14ORF104 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.619000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.789800E-01
Normal-vs-Stage2
6.170000E-01
Normal-vs-Stage3
1.483540E-02
Normal-vs-Stage4
2.511800E-01
Stage1-vs-Stage2
5.079600E-01
Stage1-vs-Stage3
7.909700E-02
Stage1-vs-Stage4
1.410160E-01
Stage2-vs-Stage3
1.654770E-01
Stage2-vs-Stage4
2.324400E-03
Stage3-vs-Stage4
7.716200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.799400E-01
Normal-vs-AfricanAmerican
9.195400E-01
Normal-vs-Asian
5.245200E-01
Caucasian-vs-AfricanAmerican
8.192400E-01
Caucasian-vs-Asian
3.899600E-01
AfricanAmerican-vs-Asian
5.177600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.407800E-01
Normal-vs-Female
7.984800E-01
Male-vs-Female
7.213000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.675600E-01
Normal-vs-Age(41-60Yrs)
9.619800E-01
Normal-vs-Age(61-80Yrs)
6.443400E-01
Normal-vs-Age(81-100Yrs)
6.076600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.394800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.780300E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.695380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.983700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.696400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.062600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.418600E-01
Normal-vs-Daily Drinker
4.580400E-01
Normal-vs-Weekly Drinker
4.320800E-01
Normal-vs-Occasional Drinker
7.311200E-01
Normal-vs-Social Drinker
8.612000E-01
Non Drinker-vs-Daily Drinker
7.906800E-01
Non Drinker-vs-Weekly Drinker
6.697800E-01
Non Drinker-vs-Occasional Drinker
3.863900E-02
Non Drinker-vs-Social Drinker
3.518000E-01
Daily Drinker-vs-Weekly Drinker
8.694000E-01
Daily Drinker-vs-Occasional Drinker
5.218400E-02
Daily Drinker-vs-Social Drinker
3.270200E-01
Weekly Drinker-vs-Occasional Drinker
7.096100E-02
Weekly Drinker-vs-Social Drinker
3.154200E-01
Occasional Drinker-vs-Social Drinker
3.736600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.733580E-01
Normal-vs-Grade 2
5.047600E-02
Normal-vs-Grade 3
4.833500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.524000E-01
Grade 1-vs-Grade 3
9.138600E-01
Grade 1-vs-Grade 4
1.733580E-01
Grade 2-vs-Grade 3
4.210200E-01
Grade 2-vs-Grade 4
5.047600E-02
Grade 3-vs-Grade 4
4.833500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.053000E-01
Normal-vs-NonDiabetic
7.402200E-01
Diabetic-vs-NonDiabetic
4.005400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.069840E-01
Normal-vs-NoPancreatitis
7.822400E-01
Pancreatitis-vs-NoPancreatitis
4.808000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.757000E-01
Normal-vs-N1
6.928800E-01
N0-vs-N1
6.440000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.981400E-01
Normal-vs-TP53-NonMutant
9.505800E-01
TP53-Mutant-vs-TP53-NonMutant
8.307800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
